Feedback / Questions
icovamenib (BMF-219) - Biomea Fusion
Komzifti (ziftomenib) - Kura Oncology, Kyowa Kirin
pivekimab sunirine (PVEK) - AbbVie
Revuforj (revumenib) - Syndax Pharma
https://www.researchtopractice.com/Meetings/FSS2024/AML
Oct 6, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next